|
|
|
|
| LEADER |
01728nam a2200361Ia 4500 |
| 001 |
9d84ad92-4c43-444c-b23c-dd34d5c41b01 |
| 005 |
20240901000000.0 |
| 008 |
061109s2006 maua b 000 0 eng d |
| 035 |
|
|
|a (MCM)001403216MIT01
|
| 035 |
|
|
|a (OCoLC)75547691
|
| 040 |
|
|
|a IUL
|c IUL
|d GZM
|d IXA
|d MYG
|
| 049 |
|
|
|a MYGG
|
| 090 |
|
|
|a HB1
|b .N265 no.12643
|
| 099 |
|
|
|a H11.N27534 no.12643
|
| 100 |
1 |
|
|a Frank, Richard G
|
| 245 |
1 |
0 |
|a Cost-offsets of new medications for treatment of schizophrenia /
|c Richard G. Frank, Thomas G. McGuire, Sharon-Lise Normand
|
| 260 |
|
|
|a Cambridge, Mass. :
|b National Bureau of Economic Research,
|c c2006
|
| 300 |
|
|
|a 25 p. :
|b ill. ;
|c 22 cm
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a NBER working paper series ;
|v working paper 12643
|
| 500 |
|
|
|a "October 2006."
|
| 504 |
|
|
|a Includes bibliographical references (p. 24-25)
|
| 530 |
|
|
|a Also available online via the World Wide Web
|
| 650 |
|
0 |
|a Schizophrenia
|x Treatment
|x Economic aspects
|
| 650 |
|
7 |
|a Schizophrenia
|x Treatment
|2 fast
|
| 700 |
1 |
|
|a McGuire, Thomas G.,
|d 1950-
|
| 700 |
1 |
|
|a Normand, Sharon-Lise,
|d 1961-
|
| 710 |
2 |
|
|a National Bureau of Economic Research
|
| 830 |
|
0 |
|a Working paper series (National Bureau of Economic Research) ;
|v working paper no. 12643
|
| 999 |
1 |
0 |
|i 9d84ad92-4c43-444c-b23c-dd34d5c41b01
|l 990014032160106761
|s US-MCM
|m cost_offsets_of_new_medications_for_treatment_of_schizophrenia_____________2006_______natioa________________________________________frank__richard_g___________________e
|
| 999 |
1 |
1 |
|l 990014032160106761
|s ISIL:US-MCM
|t BKS
|a LSA OCC
|b 39080031598243
|c H11.N27534 no.12643
|d 0
|x BOOK
|y 23493075490006761
|p UNLOANABLE
|